Patents by Inventor Chia-Jung Liao

Chia-Jung Liao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11937932
    Abstract: An acute kidney injury predicting system and a method thereof are proposed. A processor reads the data to be tested, the detection data, the machine learning algorithm and the risk probability comparison table from a main memory. The processor trains the detection data according to the machine learning algorithm to generate an acute kidney injury prediction model, and inputs the data to be tested into the acute kidney injury prediction model to generate an acute kidney injury characteristic risk probability and a data sequence table. The data sequence table lists the data to be tested in sequence according to a proportion of each of the data to be tested in the acute kidney injury characteristics. The processor selects one of the medical treatment data from the risk probability comparison table according to the acute kidney injury characteristic risk probability.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: March 26, 2024
    Assignees: TAICHUNG VETERANS GENERAL HOSPITAL, TUNGHAI UNIVERSITY
    Inventors: Chieh-Liang Wu, Chun-Te Huang, Cheng-Hsu Chen, Tsai-Jung Wang, Kai-Chih Pai, Chun-Ming Lai, Min-Shian Wang, Ruey-Kai Sheu, Lun-Chi Chen, Yan-Nan Lin, Chien-Lun Liao, Ta-Chun Hung, Chien-Chung Huang, Chia-Tien Hsu, Shang-Feng Tsai
  • Patent number: 11698357
    Abstract: The present disclosure provides a method for screening, isolating and purifying analytes.
    Type: Grant
    Filed: July 5, 2019
    Date of Patent: July 11, 2023
    Assignee: CHANG GUNG UNIVERSITY
    Inventors: Min-Hsien Wu, Po-Yu Chu, Wen-Pin Chou, Chia-Jung Liao
  • Publication number: 20210063384
    Abstract: Methods of assessing circulating tumor cells (CTCs) and methods of using the data obtained from assessing CTCs are provided. The methods employ negative selection and 3D cell culture techniques to isolate and culture CTCs. Those CTCs then can be used in different bioassays or evaluations, such as to determine tumor morphology, monitor tumor status, predict prognosis, provide treatment suggestion, and assess treatment effectiveness.
    Type: Application
    Filed: December 20, 2019
    Publication date: March 4, 2021
    Inventors: MIN-HSIEN WU, CHIA-JUNG LIAO
  • Publication number: 20200340998
    Abstract: The present disclosure provides a method for diagnosing cancer, assessing cancer prognosis, monitoring cancer, or assessing effectiveness of cancer treatment. The present disclosure also provides a method for diagnosing cancer, assessing cancer prognosis, monitoring cancer, or assessing effectiveness of cancer treatment by using an atypical circulating tumor cell.
    Type: Application
    Filed: November 12, 2019
    Publication date: October 29, 2020
    Inventors: Min-Hsien Wu, Chia-Jung Liao, Feng-Chung Hung
  • Publication number: 20200240950
    Abstract: The present disclosure provides a method for screening, isolating and purifying analytes.
    Type: Application
    Filed: July 5, 2019
    Publication date: July 30, 2020
    Inventors: Min-Hsien Wu, Po-Yu Chu, Wen-Pin Chou, Chia-Jung Liao